Salta al contenuto principale
Passa alla visualizzazione normale.

VINCENZA CALVARUSO

Curriculum e ricerca

Insegnamenti

Anno accademico Codice della materia Nome della materia CFU Corso di studi
2023/2024 20360 GASTROENTEROLOGY (MODULO) 3 NURSING
2023/2024 21851 MALATTIE DELL’APPARATO DIGERENTE E PATOLOGIE DELLA NUTRIZIONE (MODULO) 3 INFERMIERISTICA (ABILITANTE ALLA PROFESSIONE SANITARIA DI INFERMIERE)
2023/2024 21846 MEDICINA INTERNA, GASTROENTEROLOGIA E FARMACOLOGIA C.I. 9 INFERMIERISTICA (ABILITANTE ALLA PROFESSIONE SANITARIA DI INFERMIERE)

Pubblicazioni

Data Titolo Tipologia Scheda
2024 Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH Articolo in rivista Vai
2023 Depth effect on point shear wave velocity elastography: Evidence in a chronic hepatitis C patient cohort Articolo in rivista Vai
2023 Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study Articolo in rivista Vai
2023 Child-Pugh Class and Not Thrombocytopenia Impacts the Risk of Complications of Endoscopic Band Ligation in Patients with Cirrhosis and High Risk Varices Articolo in rivista Vai
2023 Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort Articolo in rivista Vai
2023 Heart rate variability is associated with disease severity and portal hypertension in cirrhosis Articolo in rivista Vai
2023 The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight Articolo in rivista Vai
2023 Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease Articolo in rivista Vai
2023 Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity Articolo in rivista Vai
2023 Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study Articolo in rivista Vai
2023 Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort Articolo in rivista Vai
2022 RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices Articolo in rivista Vai
2022 Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model Articolo in rivista Vai
2022 Primary biliary cholangitis: perception and expectation of illness Articolo in rivista Vai
2022 Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974] Nota o commento Vai
2022 Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis Articolo in rivista Vai
2022 Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) Nota o commento Vai
2022 Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development Articolo in rivista Vai
2022 Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid Articolo in rivista Vai
2022 Baveno VII – Renewing consensus in portal hypertension Articolo in rivista Vai
2021 Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort Articolo in rivista Vai
2021 Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b. Articolo in rivista Vai
2021 Reply to: “Hepatic benefits of HCV cure: Don't forget coagulation!” Recensione in rivista Vai
2021 Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy Articolo in rivista Vai
2021 Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach Articolo in rivista Vai
2021 An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. Articolo in rivista Vai
2021 First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials Articolo in rivista Vai
2021 X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis. Articolo in rivista Vai
2021 Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study Articolo in rivista Vai
2021 Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease Articolo in rivista Vai
2021 Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C Articolo in rivista Vai
2021 Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals Articolo in rivista Vai
2021 Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort Articolo in rivista Vai
2021 Real-world experience with obeticholic acid in patients with primary biliary cholangitis. Articolo in rivista Vai
2020 Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study Articolo in rivista Vai
2020 Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis Articolo in rivista Vai
2020 Hepatic benefits of HCV cure Articolo in rivista Vai
2020 On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites Articolo in rivista Vai
2020 Towards personalized screening for hepatocellular carcinoma: Still not there Recensione in rivista Vai
2020 Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study Articolo in rivista Vai
2020 Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) Articolo in rivista Vai
2019 Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. Articolo in rivista Vai
2019 Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program. Articolo in rivista Vai
2019 Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data Articolo in rivista Vai
2019 Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience Abstract in atti di convegno pubblicato in rivista Vai
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Abstract in atti di convegno pubblicato in rivista Vai
2019 Current epidemiology of HCV in Sicily: the RESIST-HCV model Abstract in atti di convegno pubblicato in rivista Vai
2019 Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) Articolo in rivista Vai
2019 Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy Articolo in rivista Vai
2019 Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience Articolo in rivista Vai
2019 Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Articolo in rivista Vai
2019 Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients Articolo in rivista Vai
2018 HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals Articolo in rivista Vai
2018 Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) Nota o commento Vai
2018 Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis Articolo in rivista Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Articolo in rivista Vai
2018 High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. Articolo in rivista Vai
2018 Real life experiences in HCV management in 2018 Articolo in rivista Vai
2018 Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. Articolo in rivista Vai
2018 Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort Poster pubblicato in rivista Vai
2018 Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis Articolo in rivista Vai
2018 Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study Articolo in rivista Vai
2018 Predictors of Re‐bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS) Articolo in rivista Vai
2018 Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis Articolo in rivista Vai
2018 The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance Abstract in atti di convegno pubblicato in rivista Vai
2018 Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? Lettera Vai
2018 Is global elimination of HCV realistic? Articolo in rivista Vai
2017 Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV Articolo in rivista Vai
2017 Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens Articolo in rivista Vai
2017 HBV recurrence after HCV clearance on DAAs: Sometimes they come back Nota o commento Vai
2017 Hepatocellular carcinoma and direct-acting antivirals: A never ending story? Articolo in rivista Vai
2017 Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response Articolo in rivista Vai
2017 A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network Articolo in rivista Vai
2017 Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies Articolo in rivista Vai
2017 Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study Articolo in rivista Vai
2017 Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication Articolo in rivista Vai
2016 Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension Articolo in rivista Vai
2016 Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model Articolo in rivista Vai
2016 AISF position paper on liver disease and pregnancy. Articolo in rivista Vai
2016 Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference Articolo in rivista Vai
2016 Why do I treat my patients with mild hepatitis C? Articolo in rivista Vai
2016 HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels Articolo in rivista Vai
2016 Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? Articolo in rivista Vai
2016 Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. Articolo in rivista Vai
2016 AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF). Articolo in rivista Vai
2016 Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease Articolo in rivista Vai
2015 Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis Articolo in rivista Vai
2015 Meccanismi immunologici e molecolari del danno epatico da farmaci Articolo in rivista Vai
2015 Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye. Review essay (rassegna critica) Vai
2015 Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis Articolo in rivista Vai
2015 Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. Articolo in rivista Vai
2015 Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program Articolo in rivista Vai
2015 Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis Articolo in rivista Vai
2014 Clinical implications of the hyperdynamic syndrome in cirrhosis. Articolo in rivista Vai
2014 Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin Articolo in rivista Vai
2014 Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Articolo in rivista Vai
2014 The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene Abstract in rivista Vai
2014 Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis. Articolo in rivista Vai
2014 An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. Articolo in rivista Vai
2013 Immunological alterations in hepatitis C virus infection Articolo in rivista Vai
2013 Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B Articolo in rivista Vai
2013 Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation Articolo in rivista Vai
2013 Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis Articolo in rivista Vai
2013 MECCANISMI IMMUNOLOGICI E MOLECOLARI DEL DANNO EPATICO DA FARMACI eedings Vai
2013 Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. Articolo in rivista Vai
2013 HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC Abstract in rivista Vai
2013 A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis Abstract in rivista Vai
2013 Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. Articolo in rivista Vai
2013 Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance Articolo in rivista Vai
2012 The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis Articolo in rivista Vai
2012 Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation Articolo in rivista Vai
2012 Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea Articolo in rivista Vai
2012 Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV Abstract in rivista Vai
2012 IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Articolo in rivista Vai
2011 Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients Articolo in rivista Vai
2011 COMPUTER ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN: RELATIONSHIP TO ESOPHAGEAL VARICES, LIVER DECOMPENSATION AND SVR IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS Tesi di dottorato pre 2013 Vai
2011 Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis Recensione in rivista Vai
2011 Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2011 Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis Articolo in rivista Vai
2011 Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation. Articolo in rivista Vai
2011 PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE Abstract in rivista Vai
2011 LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION Abstract in rivista Vai
2011 Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects Articolo in rivista Vai
2011 Fibrosis in chronic viral hepatitis Articolo in rivista Vai
2010 Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. Articolo in rivista Vai
2010 Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human? Recensione in rivista Vai
2010 Histological subclassification of cirrhosis Recensione in rivista Vai
2010 Critically ill patients with cirrhosis and low serum sodium. Articolo in rivista Vai
2010 Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy Articolo in rivista Vai
2009 Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Articolo in rivista Vai
2009 Impact of Tips Preliver Transplantation for the Outcome Posttransplantation Articolo in rivista Vai
2009 RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. Articolo in rivista Vai
2009 PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response eedings Vai
2009 Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy Articolo in rivista Vai
2009 A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. Articolo in rivista Vai
2009 PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response eedings Vai
2009 Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis Articolo in rivista Vai
2009 An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers Articolo in rivista Vai
2009 Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. Articolo in rivista Vai
2009 Computer-Assisted Image Analysis of Liver Collagen: Relationship to Ishak Scoring and Hepatic Venous Pressure Gradient Articolo in rivista Vai
2009 PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE Abstract in rivista Vai
2009 HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION Abstract in rivista Vai
2009 Implication of Normal Liver Enzymes in Liver Disease Articolo in rivista Vai
2008 TACE versus TAE as therapy for hepatocellular carcinoma. Articolo in rivista Vai
2008 Coagulation and fibrosis in chronic liver disease. Articolo in rivista Vai
2008 Muscle cramps in cirrhosis: the therapeutic value of quinine. Is it underused? Articolo in rivista Vai
2008 Models for non-alcoholic fatty liver disease: a link with vascular risk. Articolo in rivista Vai
2008 CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY eedings Vai
2008 Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. Articolo in rivista Vai
2007 The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study eedings Vai
2007 Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial Articolo in rivista Vai
2007 The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study eedings Vai
2006 Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial Articolo in rivista Vai
2006 The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. Articolo in rivista Vai
2006 High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C Articolo in rivista Vai